Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee Roth

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Developmental Biology|February 21, 2012
Matrix metalloproteinase 9/gelatinase B is required for neural crest cell migrationEfrat Monsonego-Ornan, Jenia Kosonovsky, Avi Bar, et al.
Cell Reports|March 19, 2013
Calponin 2 acts as an effector of noncanonical Wnt-mediated cell polarization during neural crest cell migrationBärbel Ulmer, Cathrin Hagenlocher, Silke Schmalholz, et al.
Science Signaling|January 10, 2019
Phosphorylation of the phosphatase PTPROt at Tyr<sup>399</sup> is a molecular switch that controls osteoclast activity and bone mass in vivoLee Roth, Jean Wakim, Elad Wasserman, et al.
Nature Communications|November 3, 2024
Oncogenic EML4-ALK assemblies suppress growth factor perception and modulate drug toleranceDavid Gonzalez-Martinez, Lee Roth, Thomas R Mumford, et al.
Journal of Cell Science|May 11, 2021
An SNX10-dependent mechanism downregulates fusion between mature osteoclastsMaayan Barnea-Zohar, Sabina E Winograd-Katz, Moran Shalev, et al.
Oncotarget|October 7, 2016
A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitorsValerio Gelfo, Maria Teresa Rodia, Michela Pucci, et al.
EMBO Molecular Medicine|December 8, 2017
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitorsMaicol Mancini, Hilah Gal, Nadège Gaborit, et al.
Nature Communications|October 4, 2014
Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatmentMattia Lauriola, Yehoshua Enuka, Amit Zeisel, et al.
Science Signaling|February 1, 2018
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumorsLee Roth, Swati Srivastava, Moshit Lindzen, et al.
Cell Reports|October 3, 2019
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing SarcomaSwati Srivastava, Nishanth Belugali Nataraj, Arunachalam Sekar, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Developmental Biology|February 21, 2012
Matrix metalloproteinase 9/gelatinase B is required for neural crest cell migrationEfrat Monsonego-Ornan, Jenia Kosonovsky, Avi Bar, et al.
Cell Reports|March 19, 2013
Calponin 2 acts as an effector of noncanonical Wnt-mediated cell polarization during neural crest cell migrationBärbel Ulmer, Cathrin Hagenlocher, Silke Schmalholz, et al.
Science Signaling|January 10, 2019
Phosphorylation of the phosphatase PTPROt at Tyr<sup>399</sup> is a molecular switch that controls osteoclast activity and bone mass in vivoLee Roth, Jean Wakim, Elad Wasserman, et al.
Nature Communications|November 3, 2024
Oncogenic EML4-ALK assemblies suppress growth factor perception and modulate drug toleranceDavid Gonzalez-Martinez, Lee Roth, Thomas R Mumford, et al.
Journal of Cell Science|May 11, 2021
An SNX10-dependent mechanism downregulates fusion between mature osteoclastsMaayan Barnea-Zohar, Sabina E Winograd-Katz, Moran Shalev, et al.
Oncotarget|October 7, 2016
A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitorsValerio Gelfo, Maria Teresa Rodia, Michela Pucci, et al.
EMBO Molecular Medicine|December 8, 2017
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitorsMaicol Mancini, Hilah Gal, Nadège Gaborit, et al.
Nature Communications|October 4, 2014
Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatmentMattia Lauriola, Yehoshua Enuka, Amit Zeisel, et al.
Science Signaling|February 1, 2018
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumorsLee Roth, Swati Srivastava, Moshit Lindzen, et al.
Cell Reports|October 3, 2019
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing SarcomaSwati Srivastava, Nishanth Belugali Nataraj, Arunachalam Sekar, et al.
Pageof 3